The Advisory Council on the Implementation of National Pharmacare was launched in July 2018 (for further details please see "Mid-year life sciences highlights" and "Proposed national pharmacare programme and prescription and generic drug pricing modifications"). The council recently invited all Canadians to provide their feedback on national pharmacare in order to:

help shape the Council's independent report to the Federal Government, to be presented in spring 2019… which will provide the Government with recommendations and a plan on how to move forward on national pharmacare.

Participants were invited to provide feedback online (by questionnaire or through a discussion forum) or in writing to the council by 28 September 2018.

For further information on this topic please contact Andrew Mandlsohn at Smart & Biggar/Fetherstonhaugh by telephone (+1 416 593 5514) or email (aemandlsohn@smart-biggar.ca). The Smart & Biggar/Fetherstonhaugh website can be accessed at www.smart-biggar.ca.

This article was first published by the International Law Office, a premium online legal update service for major companies and law firms worldwide. Register for a free subscription.